> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pfizer’s RSV Vaccine Moves to Panel Meeting
- URL: https://www.fdaweb.com/pfizers-rsv-vaccine-moves-to-panel-meeting/
- Published: 2023-04-10T12:00:00.000Z
- Updated: 2026-09-14T18:24:41.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5154170

*Federal Register* notice: FDA has announced a 5/18 Vaccines and Related Biological Products Advisory Committee meeting to discuss a Pfizer BLA for Abrysvo (respiratory syncytial virus vaccine). The submission is seeking an indication for preventing lower respiratory tract disease and severe lower respiratory tract disease caused by respiratory syncytial virus in infants from birth through six months of age by active immunization of pregnant individuals. To view the notice, click [here](https://public-inspection.federalregister.gov/2023-07550.pdf?ref=fdaweb.com).